Investigation Report on China Lamivudine Market, 2010-2019
Description
Acoording to the report issued by the Joint United Nations Programme on HIV and AIDS in 2014, by the end of 2013, patients with human immune deficiency virus/acquired immune deficiency syndrome (HIV/ AIDS) had amounted to 35 million and the number of new cases of HIV/AIDS had been 6000 a day on average. And by the end of 2011, patients with HIV/ AIDS in China was estimated to be 0.78 million, the number of new cases of HIV/AIDS was 48,000 and people die of diseases related with AIDS reached 28,000.
Lamivudine, an important drug for hepatitis B Virus (HBV) and AIDS, is one of the products regulated by the Chinese government to be provided to patients with AIDS (patients with hepatitis B not included) for free. As an antiviral nucleotide analog, lamivudine can competitively inhibit the synthesis and elongation of viral DNA chain. First used by some countries in Europe and North America for the treatment of AIDS in the early 1990s, lamivudine was approved by FDA to be used for the treatment of hepatitis B in 1998 after some medical experts discovered its inhibiting effect on HBV DNA in the middle 1990s. Lamivudine was approved by CFDA mainly as hepatitis B drug and began its sales in China in 1999.
Lamivudine develops fast after entering China with sales value reaching up to CNY 307 million in 2012 despite its gradual drop since 2013. GlaxoSmithKline Pharmaceuticals (Suzhou) Limited, Beijing Wansheng Pharmaceutical Co., Ltd, Burroughs Wellcome & Company (UK) and Fujian Cosunter Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which GlaxoSmithKline Pharmaceuticals (Suzhou) Limited had the largest market share of about 72% for sales value in 2014.
With the large amounts of patients with hepatitis B and AIDS in China, the market size of lamivudine is expected to have growth potential.
Readers can get at least the following information from this report:
Acoording to the report issued by the Joint United Nations Programme on HIV and AIDS in 2014, by the end of 2013, patients with human immune deficiency virus/acquired immune deficiency syndrome (HIV/ AIDS) had amounted to 35 million and the number of new cases of HIV/AIDS had been 6000 a day on average. And by the end of 2011, patients with HIV/ AIDS in China was estimated to be 0.78 million, the number of new cases of HIV/AIDS was 48,000 and people die of diseases related with AIDS reached 28,000.
Lamivudine, an important drug for hepatitis B Virus (HBV) and AIDS, is one of the products regulated by the Chinese government to be provided to patients with AIDS (patients with hepatitis B not included) for free. As an antiviral nucleotide analog, lamivudine can competitively inhibit the synthesis and elongation of viral DNA chain. First used by some countries in Europe and North America for the treatment of AIDS in the early 1990s, lamivudine was approved by FDA to be used for the treatment of hepatitis B in 1998 after some medical experts discovered its inhibiting effect on HBV DNA in the middle 1990s. Lamivudine was approved by CFDA mainly as hepatitis B drug and began its sales in China in 1999.
Lamivudine develops fast after entering China with sales value reaching up to CNY 307 million in 2012 despite its gradual drop since 2013. GlaxoSmithKline Pharmaceuticals (Suzhou) Limited, Beijing Wansheng Pharmaceutical Co., Ltd, Burroughs Wellcome & Company (UK) and Fujian Cosunter Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which GlaxoSmithKline Pharmaceuticals (Suzhou) Limited had the largest market share of about 72% for sales value in 2014.
With the large amounts of patients with hepatitis B and AIDS in China, the market size of lamivudine is expected to have growth potential.
Readers can get at least the following information from this report:
- market size of lamivudine in China
- competitive landscape of lamivudine in Chinese market
- price of lamivudine made by different enterprises in China
- market outlook of lamivudine in China
- manufacturers of anti-HBV drugs
- manufacturers of anti-AIDS drugs
- investors/ research institutions interested in Chinese medicine market
- any interest in the Chinese medicine market, please contact CRI for customized survey service
1 RELATED CONCEPTS OF LAMIVUDINE
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF LAMIVUDINE IN CHINA
2.1 Patent and Approval Status of Lamivudine in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF LAMIVUDINE IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF LAMIVUDINE IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF LAMIVUDINE IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF LAMIVUDINE IN CHINESE HOSPITALS IN 2014
6.1 Beijing Wansheng Pharmaceutical Co., Ltd (Trade Name: Wanshenglike)
6.2 Burroughs Wellcome & Company (UK) (Trade Name: Heptodin)
6.3 Anhui Biochem United Pharmaceutical Co., Ltd (Trade Name: Yinding)
6.4 Hunan Qianjin Xiangjiang Pharmaceutical Industry Co., Ltd (Trade Name: Jianganling)
6.5 Fujian Cosunter Pharmaceutical Co., Ltd (Trade Name: Heganding)
6.6 GlaxoSmithKline Pharmaceuticals (Suzhou) Limited (Trade Name: Heptodin)
7 MAJOR MANUFACTURERS OF LAMIVUDINE IN CHINESE MARKET, 2010-2014
7.1 Anhui Biochem United Pharmaceutical Co., Ltd
7.2 Fujian Cosunter Pharmaceutical Co., Ltd
7.3 Beijing Wansheng Pharmaceutical Co., Ltd
7.4 GlaxoSmithKline Pharmaceuticals (Suzhou) Limited
7.5 Hunan Qianjin Xiangjiang Pharmaceutical Industry Co., Ltd
8 MARKET OUTLOOK OF LAMIVUDINE IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
TABLE OF SELECTED CHARTS
Chart Patent Status of Lamivudine in China
Chart Approval Information of Lamivudine in China
Chart Sales Status of Lamivudine in China
Chart Sales Value of Lamivudine in China, 2010-2014
Chart Sales Value of Lamivudine in Some Regions in China, 2010-2014
Chart Sales Volume of Lamivudine in China, 2010-2014
Chart Market Share of TOP3 Manufacturers of Lamivudine for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Lamivudine Made by GlaxoSmithKline Pharmaceuticals (Suzhou) Limited in China, 2010-2014
Chart Sales Value and Market Share of Lamivudine Made by Burroughs Wellcome & Company (UK) in China, 2010-2014
Chart Sales Value and Market Share of Lamivudine Made by Fujian Cosunter in China, 2010-2014
Chart Sales Value and Market Share of Lamivudine Tablets in China, 2010-2014
Chart Sales Value and Market Share of Lamivudine Capsules in China, 2010-2014
Chart Sales Volume and Market Share of Lamivudine Tablets in China, 2010-2014
Chart Sales Volume and Market Share of Lamivudine Capsules in China, 2010-2014
Chart Price of Lamivudine Made by Beijing Wansheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Lamivudine Made by Burroughs Wellcome & Company (UK) in Some Chinese Cities in 2014
Chart Price of Lamivudine Made by Anhui Biochem United Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Lamivudine Made by Hunan Qianjin Xiangjiang Pharmaceutical Industry Co., Ltd in Some Chinese Cities in 2014
Chart Price of Lamivudine Made by Fujian Cosunter Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Lamivudine Made by GlaxoSmithKline Pharmaceuticals (Suzhou) Limited in Some Chinese Cities in 2014
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF LAMIVUDINE IN CHINA
2.1 Patent and Approval Status of Lamivudine in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF LAMIVUDINE IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF LAMIVUDINE IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF LAMIVUDINE IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF LAMIVUDINE IN CHINESE HOSPITALS IN 2014
6.1 Beijing Wansheng Pharmaceutical Co., Ltd (Trade Name: Wanshenglike)
6.2 Burroughs Wellcome & Company (UK) (Trade Name: Heptodin)
6.3 Anhui Biochem United Pharmaceutical Co., Ltd (Trade Name: Yinding)
6.4 Hunan Qianjin Xiangjiang Pharmaceutical Industry Co., Ltd (Trade Name: Jianganling)
6.5 Fujian Cosunter Pharmaceutical Co., Ltd (Trade Name: Heganding)
6.6 GlaxoSmithKline Pharmaceuticals (Suzhou) Limited (Trade Name: Heptodin)
7 MAJOR MANUFACTURERS OF LAMIVUDINE IN CHINESE MARKET, 2010-2014
7.1 Anhui Biochem United Pharmaceutical Co., Ltd
7.2 Fujian Cosunter Pharmaceutical Co., Ltd
7.3 Beijing Wansheng Pharmaceutical Co., Ltd
7.4 GlaxoSmithKline Pharmaceuticals (Suzhou) Limited
7.5 Hunan Qianjin Xiangjiang Pharmaceutical Industry Co., Ltd
8 MARKET OUTLOOK OF LAMIVUDINE IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
TABLE OF SELECTED CHARTS
Chart Patent Status of Lamivudine in China
Chart Approval Information of Lamivudine in China
Chart Sales Status of Lamivudine in China
Chart Sales Value of Lamivudine in China, 2010-2014
Chart Sales Value of Lamivudine in Some Regions in China, 2010-2014
Chart Sales Volume of Lamivudine in China, 2010-2014
Chart Market Share of TOP3 Manufacturers of Lamivudine for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Lamivudine Made by GlaxoSmithKline Pharmaceuticals (Suzhou) Limited in China, 2010-2014
Chart Sales Value and Market Share of Lamivudine Made by Burroughs Wellcome & Company (UK) in China, 2010-2014
Chart Sales Value and Market Share of Lamivudine Made by Fujian Cosunter in China, 2010-2014
Chart Sales Value and Market Share of Lamivudine Tablets in China, 2010-2014
Chart Sales Value and Market Share of Lamivudine Capsules in China, 2010-2014
Chart Sales Volume and Market Share of Lamivudine Tablets in China, 2010-2014
Chart Sales Volume and Market Share of Lamivudine Capsules in China, 2010-2014
Chart Price of Lamivudine Made by Beijing Wansheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Lamivudine Made by Burroughs Wellcome & Company (UK) in Some Chinese Cities in 2014
Chart Price of Lamivudine Made by Anhui Biochem United Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Lamivudine Made by Hunan Qianjin Xiangjiang Pharmaceutical Industry Co., Ltd in Some Chinese Cities in 2014
Chart Price of Lamivudine Made by Fujian Cosunter Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Lamivudine Made by GlaxoSmithKline Pharmaceuticals (Suzhou) Limited in Some Chinese Cities in 2014
